Multidisciplinary Collaborative and Refined Nursing for a Patient with Severe Toxic Epidermal Necrolysis
Abstract
This paper summarizes the nursing experience of a 75-year-old patient who developed exfoliative dermatitis-type drug eruption induced by cold medicine and progressed to toxic epidermal necrolysis (TEN). The core nursing measures included (1) Establishing a multidisciplinary team and implementing bundled care led by trauma specialist nurses; (2) Precise wound management using the “three-stage debridement method” and silver ion dressings; (3) Implementing multimodal analgesia based on dynamic pain assessment; (4) Strengthening fluid, electrolyte, and nutritional management; and (5) Providing individualized psychological support. After 14 days of treatment and nursing, the patient’s wounds were completely epithelialized, infection indicators returned to normal, pain was effectively controlled, and the patient was discharged successfully. No serious complications were observed during the 6-month follow-up. For elderly critically ill patients with TEN, constructing a systematic nursing model based on multidisciplinary collaboration and centered on trauma care is crucial for improving patient outcomes.
References
Creamer D, Walsh S, Dziewulski P, et al., 2016, UK Guidelines for the Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in Adults 2016. Journal of Plastic, Reconstructive & Aesthetic Surgery, 69(6): e119–e153.
Tian Q, Chen W, Chen L, 2018, Nursing Care for a Patient with Severe Hepatitis B Complicated by Bullous Epidermal Necrolysis Drug Eruption. Journal of Practical Clinical Nursing, 3(08): 140.
Qi X, Peng B, Zhang H, 2025, Correlation Between Psychological Resilience and Quality of Life During the Intensive Care Unit–Rehabilitation Transition Period in Elderly Patients with Hemorrhagic Stroke. Chinese Journal of Multiorgan Diseases in the Elderly, 24(01): 50–54.
Zhang J, 2023, Analysis of Infections and Related Factors in 92 Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis, thesis, Lanzhou University.
Xu H, Huang R, Zhuang Y, et al., 2025, Retrospective Analysis of Clinical Characteristics and Department Distribution of Severe Drug Eruptions in Hospitalized Patients. Journal of Clinical and Experimental Medicine, 24(16): 1755–1759.
Lv C, 2024, Severe Drug Eruption: A “Fragile” Skin Condition and a Severe Test of Life//Guangdong Provincial Society of Cancer Rehabilitation. Proceedings of the 2024 “Healthy Greater Bay Area” Science Popularization Forum and the 6th Health Science Popularization Works Collection Activity. Intensive Care Unit, Shenzhen People’s Hospital: 287–289.
